Consolidated Statement of Changes in Equity - EUR (€) € in Thousands |
Share capital.
Warrant A
Gilead
|
Share capital. |
Share premium account
Warrant A
Gilead
|
Share premium account |
Translation differences |
Other reserves |
Accumulated losses |
Warrant A
Gilead
|
Total |
|---|---|---|---|---|---|---|---|---|---|
| Balance at beginning of period at Dec. 31, 2016 | € 223,928 | € 649,135 | € (1,090) | € (1,000) | € (112,272) | € 758,701 | |||
| Net income/loss (-) | (115,704) | (115,704) | |||||||
| Other comprehensive income / loss (-) | (664) | (260) | (924) | ||||||
| Total comprehensive income / loss (-) | (664) | (260) | (115,704) | (116,629) | |||||
| Share-based compensation | 16,536 | 16,536 | |||||||
| Issue of new shares | 23,331 | 340,593 | 363,924 | ||||||
| Share issue costs | (15,837) | (15,837) | |||||||
| Exercise of warrants | 1,992 | 3,296 | 5,288 | ||||||
| Balance at end of period at Dec. 31, 2017 | 233,414 | 993,025 | (1,754) | (1,260) | (211,441) | 1,011,983 | |||
| Restated total equity at January 1 | 233,414 | 993,025 | (1,754) | (641) | (295,280) | 928,766 | |||
| Change in accounting policy (IFRS 15) at Dec. 31, 2017 | (83,220) | (83,220) | |||||||
| Change in accounting policy (IFRS 9) at Dec. 31, 2017 | 619 | (619) | |||||||
| Net income/loss (-) | (29,259) | (29,259) | |||||||
| Other comprehensive income / loss (-) | 197 | (94) | 103 | ||||||
| Total comprehensive income / loss (-) | 197 | (94) | (29,259) | (29,155) | |||||
| Share-based compensation | 26,757 | 26,757 | |||||||
| Issue of new shares | 16,021 | 280,167 | 296,188 | ||||||
| Share issue costs | (15,964) | (15,964) | |||||||
| Exercise of warrants | 3,069 | 4,588 | 7,657 | ||||||
| Balance at end of period at Dec. 31, 2018 | 236,540 | 1,277,780 | (1,557) | (735) | (297,779) | 1,214,249 | |||
| Restated total equity at January 1 | 236,540 | 1,277,780 | (1,557) | (735) | (297,363) | 1,214,665 | |||
| Change in accounting policy (IFRS 16) at Dec. 31, 2018 | 416 | 416 | |||||||
| Net income/loss (-) | 149,845 | 149,845 | |||||||
| Other comprehensive income / loss (-) | 415 | (4,107) | (3,692) | ||||||
| Total comprehensive income / loss (-) | 415 | (4,107) | 149,845 | 146,154 | |||||
| Share-based compensation | 38,297 | 38,297 | |||||||
| Derecognition of financial liability from share subscription agreement and warrant A | 135,702 | 135,702 | |||||||
| Issue of new shares | 36,945 | 923,142 | 960,087 | ||||||
| Share issue costs | (4,447) | (4,447) | |||||||
| Exercise of warrants | € 14,162 | 4,082 | € 353,873 | 13,085 | € 368,035 | 17,167 | |||
| Balance at end of period at Dec. 31, 2019 | € 287,282 | € 2,703,583 | € (1,142) | € (4,842) | € (109,223) | € 2,875,658 |